Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Kelie H. Luby

I first heard about Mint Medical in 2013 when a colleague said: ‘you have to see this software - this will change everything.’ At this time, I was part of the imaging Contract Research Organizations (iCROs) ecosystem, working in the area of imaging centrally read clinical trials, primarily in oncology. What my colleague and I realized was that mint Lesion™ allows you to ask for more.

Related Resources

Related Resources

A diagram and a CT scan visualizing tumor growth rate in patients with refractory or relapsed lymphoma

Study with mint Lesion™ Uncovers the Impact of Tumor Growth Rate in Predicting the Efficacy of CAR-T-cell Therapy in Lymphoma Patients

A recent study conducted by Dr. med. Michael Winkelmann and his colleagues at the LMU Klinikum München explored the association between TGR dynamics…

ESOI-EORTC Hands-On Workshop 2023

11/02 to 11/04/2023 MUNICH, GERMANY

Imaging in assessing response to cancer therapy – a hands-on course

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…